Inhibition of the Oncogene Product p185erbB-2 in Vitro and in Vivo by Geldanamycin and Dihydrogeldanamycin Derivatives

Journal of Medicinal Chemistry

Volumn 38, Issue 19, 1995, Pages 3806-3812

  Schnur, R C ^a   Corman, M L ^a   Gallaschun, R J ^a   Cooper, B A ^a   Dee, M F ^a   Doty, J L ^a   Muzzi, M L ^a   Moyer, J D ^a   DiOrio, C I ^a   Barbacci, E G ^a   Miller, P E ^a   O'Brien A T ^a   Morin, M J ^a   Foster, B A ^a   Pollack, V A ^a   Savage, D M ^a   Sloan, D E ^a   Pustilnik, L R ^a   Moyer, M P ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

17 ALLYLAMINO 17 DEMETHOXYGELDANAMYCIN; 4,5 DIHYDROGELDANAMYCIN; ANSAMYCIN DERIVATIVE; ANTINEOPLASTIC ANTIBIOTIC; GELDANAMYCIN; GELDANAMYCIN DERIVATIVE; HERBIMYCIN A; HYDROQUINONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; EMBRYO; EMBRYO CELL; ENZYME INHIBITION; GROWTH INHIBITION; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; NUDE MOUSE; PROTO ONCOGENE; RAT; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

ANIMAL; ANTIBIOTICS; ANTIBIOTICS, ANTINEOPLASTIC; BREAST NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMAN; MICE; MICE, NUDE; PHOSPHOTYROSINE; PROTEIN-TYROSINE KINASE; QUINONES; RATS; RECEPTOR, ERBB-2; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0029122080     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00019a010     Document Type: Article

References (17)

1. Slamon, D. A.; Clark, G. M.; Wong, S. G.; Levin, W. J.; Ullrich, A.; McGuire, W. L. Science 1989, 244, 707.
2. Miller, P.; DiOrio, C.; Cullen, W.; Moyer, J. D. Am. Assoc. Cancer Res. Proc. 1993, 34, 344.
3. Cullen, W.; Jefferson, M.; Moyer, J. D.; Moyer, M.; Sciavolino, F. Presented at the CSM/SIM Meeting, Toronto, Canada, 1993; Abstract No. P55.
4. Miller, P.; DiOrio, C.; Moyer, M.; Schnur, R. C.; Bruskin, A.; Cullen, W.; Moyer, J. D. Cancer Res. 1994, 54, 2724.
5. Sasaki, K.; Yasuda, H.; Onodera, K.-J. Antibiotics 1979, 32, 849.
6. Li, L. H.; Clark, T. D.; Cowie, C. H.; Rinehart, K. L., Jr. Cancer Treat. Rep. 1977, 61, 815.
7. Schnur, R. C.; Gallaschun, R. J.; Corman, M. L.; Olson, B. A. C.; Dee, M. F.; Doty, J. L.; Muzzi, M.; DiOrio, C. I.; Barbacci, E. G.; Miller, P. E.; Moyer, J. D.; Moyer, M. P. Geldanamycin Derivatives as ErbB-2 Oncogene Inhibitors and Antitumor Agents: Synthesis and SAR of 11-, 17-, and 4, 5-Dihydro Analogs. Presented at the 207th Meeting of the ACS, San Diego, CA, April 19, 1994; Abstr. Paper Am. Chem. Soc. MEDI 75.
8. Schnur, R. C.; Corman, M. L.; Gallaschun, R. J.; Oison, B. A. C.; Dee, M. F.; Doty, J. L.; Muzzi, M.; DiOrio, C. I.; Barbacci, E. G.; Miller, P. E.; Moyer, J. D.; Moyer, M. P. Inhibition of the Oncogene ErbB-2 by Geldanamycin Derivatives: Synthesis and SAR of 7-and 22-Analogs. Presented at the 207th Meeting of the ACS, San Diego, CA, April 19, 1994; Abstr. Paper Am. Chem. Soc. MEDI 76.
9. Schnur, R. C.; Corman, M. L.; Gallaschun, R. J.; Cooper, B. A.; Dee, M. F.; Doty, J. L.; Muzzi, M. L.; DiOrio, C. I.; Barbacci, E. G.; Miller, P. E.; Pollack, V. A.; Savage, D. M.; Sloan, D. E.; Pustilnik, L. R.; Moyer, J. D.; Moyer, M. P. J. Med. Chem. 1995, 38, 3813-3820.
10. Shibata, K.; Satsumabayashi, S.; Sano, H.; Koyama, K.; Nakagawa, A.; Omura, S. J. Antibiot. 1986, 39, 415.
11. Rinehart, K. L.; Sobiczewski, W.; Honegger, J. F.; Enanoza, R. M.; Witty, T. R.; Lee, V. J.; Shield, L. S. Bioorg. Chem. 1977, 6, 341.
12. Rinehart, K. L.; McMillan, M. W.; Witty, T. R.; Tipton, C. D.; Shield, L. S. Bioorg. Chem. 1977, 6, 353.
13. Sasaki, S.; Rinehart, K. L., Jr.; Slomp, G.; Grostic, M. F.; Olson, E. C. J. Am. Chem. Soc. 1970, 92, 7591.
14. V. A. Pollack et al. manuscript in preparation.
15. Clark, W. M. Oxidation Reduction Potentials in Organic Systems; The Williams and Wilkins Co.: London, U. K., 1960; pp 381-383.
16. Schnur, R. C.; et al. J. Med. Chem. 1991, 34, 1975.
17. Sasaki, K.; Inoue, Y. U. S. Patent 4, 261, 989, April 14, 1981.